JP2005507888A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005507888A5 JP2005507888A5 JP2003530240A JP2003530240A JP2005507888A5 JP 2005507888 A5 JP2005507888 A5 JP 2005507888A5 JP 2003530240 A JP2003530240 A JP 2003530240A JP 2003530240 A JP2003530240 A JP 2003530240A JP 2005507888 A5 JP2005507888 A5 JP 2005507888A5
- Authority
- JP
- Japan
- Prior art keywords
- type
- botulinum toxin
- general body
- body odor
- cosmetic means
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010043024 Botulinum Toxins Proteins 0.000 claims 10
- 229940053031 botulinum toxin Drugs 0.000 claims 10
- 206010040904 Skin odour abnormal Diseases 0.000 claims 4
- 239000002537 cosmetic Substances 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 229940079593 drugs Drugs 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 208000008454 Hyperhidrosis Diseases 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000035900 sweating Effects 0.000 claims 1
Claims (7)
- ボツリヌス毒素を含む、臭汗症の予防および／または治療ならびに一般的な体臭の改善のための薬物。
- 前記ボツリヌス毒素が、Ａ型、Ｂ型、Ｃ型、Ｄ型、Ｅ型、Ｆ型、およびＧ型ボツリヌス毒素またはその誘導体もしくはその断片から選択される、請求項１に記載の薬物。
- ボツリヌス毒素を含む、一般的な体臭の改善のための化粧手段。
- 前記ボツリヌス毒素が、Ａ型、Ｂ型、Ｃ型、Ｄ型、Ｅ型、Ｆ型、およびＧ型ボツリヌス毒素またはその誘導体もしくはその断片から選択される、請求項３に記載の化粧手段。
- 臭汗症の予防および／または治療ならびに一般的な体臭の改善のための薬物の製造のためのボツリヌス毒素の使用。
- 一般的な体臭の改善のための化粧手段の製造のためのボツリヌス毒素の使用。
- 前記ボツリヌス毒素が、Ａ型、Ｂ型、Ｃ型、Ｄ型、Ｅ型、Ｆ型、およびＧ型ボツリヌス毒素またはその誘導体もしくはその断片から選択される、請求項１または請求項２に記載の使用。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10146647.1 | 2001-09-21 | ||
| DE10146647A DE10146647A1 (de) | 2001-09-21 | 2001-09-21 | Arzneimittel zur Prophylaxe und Therapie von Bromhidrosis |
| PCT/DE2002/003561 WO2003026602A2 (de) | 2001-09-21 | 2002-09-23 | Arzneimittel zur prophylaxe und therapie von bromhidrosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005507888A JP2005507888A (ja) | 2005-03-24 |
| JP2005507888A5 true JP2005507888A5 (ja) | 2006-01-05 |
| JP4966478B2 JP4966478B2 (ja) | 2012-07-04 |
Family
ID=7699852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003530240A Expired - Lifetime JP4966478B2 (ja) | 2001-09-21 | 2002-09-23 | 臭汗症の予防および治療のための薬剤 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20050036966A1 (ja) |
| EP (2) | EP1427385B1 (ja) |
| JP (1) | JP4966478B2 (ja) |
| KR (1) | KR100796243B1 (ja) |
| CN (1) | CN1289061C (ja) |
| AU (1) | AU2002349268B2 (ja) |
| CA (1) | CA2461117C (ja) |
| DE (1) | DE10146647A1 (ja) |
| EA (2) | EA011988B1 (ja) |
| HU (1) | HU230398B1 (ja) |
| IL (2) | IL160875A0 (ja) |
| MX (1) | MXPA04002614A (ja) |
| PL (1) | PL209639B1 (ja) |
| UA (1) | UA78718C2 (ja) |
| WO (1) | WO2003026602A2 (ja) |
| ZA (1) | ZA200402123B (ja) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030113349A1 (en) | 2001-12-18 | 2003-06-19 | Coleman William P. | Topically applied clostridium botulinum toxin compositions and treatment methods |
| EP2272340B1 (en) | 2002-08-19 | 2018-03-14 | Ira Sanders | Botulinum toxin |
| MXPA05009424A (es) | 2003-03-06 | 2006-02-10 | Botulinum Toxin Res Ass Inc | Tratamiento de chalazion cronico y hordeolum con la toxina botulinica. |
| US8048423B2 (en) * | 2003-12-09 | 2011-11-01 | Allergan, Inc. | Botulinum toxin therapy for skin disorders |
| EP1861112A4 (en) * | 2005-03-03 | 2009-07-22 | Revance Therapeutics Inc | COMPOSITIONS AND METHODS FOR TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF BOTULINUM TOXINS |
| US9486408B2 (en) | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
| SG177184A1 (en) | 2006-12-01 | 2012-01-30 | Anterios Inc | Amphiphilic entity nanoparticles |
| KR102080429B1 (ko) * | 2008-06-26 | 2020-02-21 | 안테리오스, 인코퍼레이티드 | 경피 운반 |
| US8454975B1 (en) * | 2010-01-11 | 2013-06-04 | Elizabeth VanderVeer | Method for enhancing skin appearance |
| AU2017360346B2 (en) | 2016-11-21 | 2023-11-23 | Eirion Therapeutics, Inc. | Transdermal delivery of large agents |
| WO2020047159A1 (en) | 2018-08-28 | 2020-03-05 | Ira Sanders | Skin therapeutics |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19852981A1 (de) * | 1998-11-17 | 2000-05-18 | Martin Schmidt | Botulinum-Toxine, deren Derivate, Analoge und molekulare Bruchstücke zur topischen epicutanen Anwendung auch in Zusammenwirken mit hautpenetrationsfördernden Substanzen und Maßnahmen in Zubereitungsformen zur Beeinflussung acetylcholinabhängiger Körperfunktionen |
| US20020086036A1 (en) * | 2000-12-05 | 2002-07-04 | Allergan Sales, Inc. | Methods for treating hyperhidrosis |
| US20030113349A1 (en) * | 2001-12-18 | 2003-06-19 | Coleman William P. | Topically applied clostridium botulinum toxin compositions and treatment methods |
-
2001
- 2001-09-21 DE DE10146647A patent/DE10146647A1/de not_active Ceased
-
2002
- 2002-09-23 UA UA20040402705A patent/UA78718C2/uk unknown
- 2002-09-23 EA EA200601238A patent/EA011988B1/ru unknown
- 2002-09-23 EP EP02781099.3A patent/EP1427385B1/de not_active Expired - Lifetime
- 2002-09-23 US US10/490,244 patent/US20050036966A1/en not_active Abandoned
- 2002-09-23 EP EP15179974.9A patent/EP2987483B1/de not_active Expired - Lifetime
- 2002-09-23 PL PL373528A patent/PL209639B1/pl unknown
- 2002-09-23 MX MXPA04002614A patent/MXPA04002614A/es active IP Right Grant
- 2002-09-23 CN CNB028185765A patent/CN1289061C/zh not_active Expired - Fee Related
- 2002-09-23 HU HU0401913A patent/HU230398B1/hu not_active IP Right Cessation
- 2002-09-23 KR KR1020047004120A patent/KR100796243B1/ko active IP Right Grant
- 2002-09-23 CA CA002461117A patent/CA2461117C/en not_active Expired - Lifetime
- 2002-09-23 WO PCT/DE2002/003561 patent/WO2003026602A2/de active Application Filing
- 2002-09-23 AU AU2002349268A patent/AU2002349268B2/en not_active Ceased
- 2002-09-23 EA EA200400436A patent/EA008146B1/ru unknown
- 2002-09-23 JP JP2003530240A patent/JP4966478B2/ja not_active Expired - Lifetime
- 2002-09-23 IL IL16087502A patent/IL160875A0/xx unknown
-
2004
- 2004-03-15 IL IL160875A patent/IL160875A/en active IP Right Grant
- 2004-03-17 ZA ZA200302123A patent/ZA200402123B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20061325L (no) | Kombinasjon av legemidler for behandling av neoplasmer | |
| DE60042598D1 (de) | Medikamente zur behandlung des syndroms der chronishen ermüdung, das mit fibromyalgie und reizdarm assoziert ist. | |
| JP2005500357A5 (ja) | ||
| KR960700742A (ko) | 아토피성질환 치료약(atopic disease remedy) | |
| JP2007514749A5 (ja) | ||
| ATE307608T1 (de) | Kombination von doctaxel und rhumab her2 zür krebsbehandlung | |
| EP1651195A4 (en) | PHARMACEUTICAL PROCESSES, DOSIERSCHEMATA AND DOSAGE FORMS FOR THE TREATMENT OF ALZHEIMER DISEASE | |
| EP1558220A4 (en) | ORAL COMPOSITIONS FOR THE TREATMENT OF DISEASES | |
| JP2005524663A5 (ja) | ||
| NO20053855L (no) | 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer. | |
| DE60222137D1 (de) | Zuckerderivate von hydromorphon, dihydromorphin und dihydroisomorphin, zusammensetzungen davon und verwendung zur vorbeugung und behandlung von schmerzen | |
| UA86344C2 (ru) | Способ лечения сосудистых заболеваний | |
| WO2006048450A3 (en) | Peptides for use in the treating obesity | |
| JP2005507888A5 (ja) | ||
| JP2006514116A5 (ja) | ||
| WO2007081486A3 (en) | Oral administration of defensins to treat intestinal diseases | |
| BR0310061A (pt) | Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições | |
| ATE357912T1 (de) | Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten | |
| WO2006131651A3 (fr) | Composition a base d'une avermectine et d’ηydrocortisone notamment pour le traitement de la rosacée | |
| DE60115054D1 (de) | Pharmazeutische zusammensetzung die trkaig2 enthält zur verwendung in der vorbeugung und/oder behandlung von krebs | |
| CA2461117A1 (en) | Botulinus toxin for treatment of body odour | |
| WO2006029487A8 (en) | Platelet factor 4 variant 1 (pf4var1) related inhibitors of angiogenesis | |
| BRPI0407140A (pt) | Droga terapêutica para vìrus | |
| WO2004056768A3 (en) | Use of substituted 2,5-diamidoindoles for the treatment of urological diseases | |
| JP2004521140A5 (ja) |